Company Filing History:
Years Active: 2013
Title: Frauke Stähler: Innovator in Sweet Taste Receptor Antagonists
Introduction
Frauke Stähler is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of nutrition and health, particularly in the development of compounds that target sweet taste receptors. Her work is especially relevant for the prevention and treatment of Type 2 diabetes.
Latest Patents
Frauke Stähler holds 1 patent for her invention titled "Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease." This patent describes precursor compounds that can be utilized to create sweet taste receptor antagonists. These compounds are aimed at preventing or treating diseases, with a focus on Type 2 diabetes. The patent also outlines various uses for these compounds, including edible compositions, nutritional preparations, and pharmaceutical formulations.
Career Highlights
Throughout her career, Frauke has worked with notable organizations such as Symrise AG and the Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke. Her experience in these institutions has allowed her to advance her research and contribute to innovative solutions in the field of nutrition.
Collaborations
Frauke has collaborated with esteemed colleagues, including Jakob Peter Ley and Michael Backes. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Frauke Stähler is a trailblazer in the development of sweet taste receptor antagonists, with a focus on combating Type 2 diabetes. Her innovative work and collaborations continue to influence the fields of nutrition and health.